Press release
Gastroparesis Drugs Market expected to provide lucrative opportunities for the market expansion in emerging countries during the forecast period
Gastroparesis Drugs Market
Gastroparesis affects the normal spontaneous movement of the muscles of stomach and interferes with the normal digestion, thus causing nausea, vomiting, and problems related with blood sugar levels & nutrition. Gastroparesis is caused due to diabetes or can develop after surgery. Recently, advanced drugs such as metoclopramide, erythromycin, antiemetics, and others are developed to treat gastroparesis.
Download PDF Report Sample with statistical info @ https://www.alliedmarketresearch.com/request-sample/4153
The major factors that drive the growth of the global gastroparesis drugs market are rise in number of surgeries that may lead to postoperative gastroparesis, increase in diabetic population, introduction of novel drugs, and surge in geriatric population. However, side effects associated with gastroparesis drugs and time-consuming regulatory approvals are expected to restrain the market growth. Conversely, huge untapped market potential in the emerging countries, such as China and India, and development of novel gastroparesis drugs are expected to provide lucrative opportunities to the market players.
The prokinetic agents segment occupied the largest share in 2016, owing to the high usage, applicability, and availability of prokinetic agents for treating gastroparesis. Furthermore, the botulinum toxin injection segment is expected to grow at the highest CAGR of 5.6% from 2017 to 2023, and is anticipated to continue its dominance during the forecast period.
The utilization rate of gastroparesis drugs for idiopathic gastroparesis is high, however post-surgical gastroparesis segment is expected to grow at a CAGR of 5.2% during the forecast period. This is attributed to increase in incidence of various types of surgeries, such as transplantation, which result in postsurgical gastroparesis.
Make an Enquiry for Promocode Of Discounted Price: @ https://www.alliedmarketresearch.com/purchase-enquiry/4153
Key findings of the Gastroparesis Drugs Market:
• Prokinetic agents segment accounted for more than four-fifths share of the global gastroparesis drugs market in 2016.
• Botulinum toxin injection segment is expected to grow at a CAGR of 5.6% from 2017 to 2023.
• Idiopathic gastroparesis segment accounted for around 34.9% share of the global gastroparesis drugs market in 2016.
• Hospitals accounted for nearly two-fifths share of the global gastroparesis drugs market in 2016.
• Pharmacies segment is expected to grow at a CAGR of 5.0% from 2017 to 2023
North America was the leading revenue contributor to the global gastroparesis drugs market, accounting for nearly one-third of the global market. This is attributed to the early approval of gastroparesis drugs and high use of these drugs due to rise in incidence of gastroparesis. However, Asia-Pacific is expected to grow at the highest CAGR of 5.5% during the study period, due to increase in affordability, surge in healthcare expenditure, and rise in awareness toward gastroparesis drugs.
Access Full info @ https://www.linkedin.com/pulse/gastroparesis-drugs-market-expected-reach-6486-million-gaikwad
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Gastroparesis Drugs Market expected to provide lucrative opportunities for the market expansion in emerging countries during the forecast period here
News-ID: 1785487 • Views: …
More Releases from Allied Market Research
Dancewear Market Trends to Witness Astonishing Growth ; to Reach USD 1.7 Billion …
According to a new report published by Allied Market Research, titled, "Dancewear Market," The dancewear market size was valued at $1.1 billion in 2020, and is estimated to reach $1.7 billion by 2030, growing at a CAGR of 4.8% from 2021 to 2030. Dancewear is a type of clothing and footwear that comes in a variety of colors, fabrics, materials, sizes, and designs that are suitable for a certain range…
Instant Coffee Market was valued at $32,926.0 million in 2022 and to grow at a C …
The global instant coffee industry was valued at $32,926.0 million in 2022, and is projected to reach $60,739.8 million by 2032, registering a CAGR of 6.4% from 2023 to 2032.
The rapid growth of instant coffee is attributed primarily to the increasing demand for quick beverage solutions. This surge is fueled by the preferences of the younger generation for instant beverages, as they seek a café-like experience within the confines of…
Event Services Market to Reflect Growth Potential with a Highest CAGR of 7.6% fr …
Allied Market Research published a report, titled, "Event Services Market by Service (Strategy, Planning, Budget, and market Development, Communication and Logistics, Attendees Management and Engagement, Event Catering, Virtual or Hybrid Event Enabler, Location Rental, Others), by Event Type (Music Concert, Festivals, Sports, Exhibitions and Conferences, Corporate Events and Seminars, Others), by End User (Corporate, Sports, Education, Entertainment, Others), by Organization (Small and Medium Enterprises, Large Enterprises, Government Bodies and NGOs):…
Eyelash Serum Market Still Has Room to Grow | Grande Cosmetics LLC, JB Cosmetics …
According to a new report published by Allied Market Research, titled, "Eyelash Serum Market," The Eyelash Serum Market Size was valued at $752.10 million in 2020, and is estimated to reach $1.3 billion by 2031, growing at a CAGR of 5.7% from 2022 to 2031. There is an increase in number of social media users, owing to rise in internet penetration. Considering this, most key players in the eyelash serum…
More Releases for Gastroparesis
Rising Diabetes Prevalence Ignites Momentum In Diabetic Gastroparesis Treatment …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Diabetic Gastroparesis Treatment Industry Market Size Be by 2025?
The overall valuation of the diabetic gastroparesis therapy sector has demonstrated consistent upward movement lately, projected to increase from $3.89 billion in 2024 to $4.05 billion in the subsequent year, reflecting a 4.2% compounded annual growth rate;…
Top Trends Transforming the Gastroparesis Drugs Market Landscape in 2025: Develo …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Gastroparesis Drugs Industry Market Size Be by 2025?
The market size for drugs treating gastroparesis has significantly increased in the past few years. The progression is predicted to continue from $5.39 billion in 2024 to $5.73 billion in 2025, representing a compound annual growth rate (CAGR)…
Rising Healthcare Expenditure Fuels Growth In The Gastroparesis Market: Transfor …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Gastroparesis Industry Market Size Be by 2025?
In recent times, the gastroparesis market size has been witnessing a consistent growth. It is projected to advance from $6.84 billion in 2024 to $7.17 billion in 2025, registering a compound annual growth rate (CAGR) of 4.9%. Several factors…
Prominent Gastroparesis Drugs Market Trend for 2025: Development Of Innovative G …
What Are the Projected Growth and Market Size Trends for the Gastroparesis Drugs Market?
In recent times, the gastroparesis drugs market has experienced substantial growth. The market size is projected to expand from $5.39 billion in 2024 to $5.73 billion in 2025, with a compound annual growth rate (CAGR) of 6.3%. Various factors like the side effects associated with current treatments, research into gastrointestinal motility, clinical requirements, patient advocacy efforts and…
Gastroparesis Market Size | Segmentation, Outlook, Industry Report
The Gastroparesis Market was valued at US$ 4,338.61 million in 2019 and is projected to reach US$ 6,025.11 million by 2027; it is expected to grow at a CAGR of 4.3%during 2020-2027.
The growth of the market is mainly attributed to the increasing prevalence of diabetes and growing geriatric population. However, side effects of gastroparesis drugs obstruct the growth of the market.
Get Exclusive Sample PDF @: https://www.premiummarketinsights.com/sample/TIP00024714?utm_source=OpenPr&utm_medium=10640
Analysis of the Top Market…
Gastroparesis Market - Transforming lives through comprehensive gastroparesis tr …
Newark, New Castle, USA: The "Gastroparesis Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Gastroparesis Market: https://www.growthplusreports.com/report/gastroparesis-market/8691
This latest report researches the industry structure, sales, revenue, price and…
